Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$8.27 USD
+0.10 (1.22%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $8.27 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Mesoblast Limited falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 6 | 8 | 10 | 7 | 32 |
Cost Of Goods | 16 | 25 | 31 | 33 | 25 |
Gross Profit | -10 | -18 | -21 | -25 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 55 | 44 | 54 | 64 | 81 |
Income After Depreciation & Amortization | -65 | -62 | -74 | -89 | -74 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 23 | 20 | 17 | 11 | 13 |
Pretax Income | -88 | -82 | -92 | -100 | -87 |
Income Taxes | 0 | 0 | 0 | -1 | -9 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -88 | -82 | -91 | -99 | -78 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -88 | -82 | -91 | -99 | -78 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -60 | -58 | -70 | -85 | -70 |
Depreciation & Amortization (Cash Flow) | 5 | 4 | 4 | 4 | 4 |
Income After Depreciation & Amortization | -65 | -62 | -74 | -89 | -74 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 98.72 | 73.91 | 64.88 | 60.51 | 52.88 |
Diluted EPS Before Non-Recurring Items | -0.89 | -1.10 | -1.40 | -1.64 | -1.48 |
Diluted Net EPS (GAAP) | -0.89 | -1.11 | -1.41 | -1.63 | -1.47 |
Fiscal Year end for Mesoblast Limited falls in the month of June .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | 1.93 |
Cost Of Goods | NA | NA | NA | NA | 6.37 |
Gross Profit | NA | NA | NA | NA | -4.44 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 13.07 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -17.51 |
Non-Operating Income | NA | NA | NA | NA | 0.00 |
Interest Expense | NA | NA | NA | NA | 4.45 |
Pretax Income | NA | NA | NA | NA | -21.96 |
Income Taxes | NA | NA | NA | NA | -0.04 |
Minority Interest | NA | NA | NA | NA | 0.00 |
Investment Gains/Losses | NA | NA | NA | NA | 0.00 |
Other Income/Charges | NA | NA | NA | NA | 0.00 |
Income From Cont. Operations | NA | NA | NA | NA | -21.92 |
Extras & Discontinued Operations | NA | NA | NA | NA | 0.00 |
Net Income (GAAP) | NA | NA | NA | NA | -21.92 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | 78.56 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | -0.28 |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | -0.28 |